Carson Wealth (CWM LLC)
XLO icon

Carson Wealth (CWM LLC)’s Xilio Therapeutics XLO Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio XLO Stock Details XLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.4K Buy
+4,206
New +$34.4K ﹤0.01% 4051

Other funds holding XLO

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Carson Wealth (CWM LLC)'s XLO Position: Q1 2026 in Review

Carson Wealth (CWM LLC) opened a new position in Xilio Therapeutics (XLO) in Q1 2026: 4,206 shares worth $35.4K. The stake represents ﹤0.01% of the portfolio and ranks #4051 among its holdings.

24 funds tracked by Wall St. Rank hold XLO as of Q1 2026.

  • Carson Wealth (CWM LLC) held 4,206 shares of Xilio Therapeutics worth $35.4K as of Q1 2026.
  • Xilio Therapeutics was a new Carson Wealth (CWM LLC) position in Q1 2026.
  • Xilio Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4051 holding.
  • 24 funds tracked by Wall St. Rank held Xilio Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.